influenza vaccine
Showing 1 - 25 of 9,307
Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults
Recruiting
- Influenza
- +2 more
- Adjuvanted Quadrivalent Inactivated Influenza Vaccine (aIIV4)
- High-Dose Quadrivalent Inactivated Influenza Vaccine (HD-IIV4)
-
Oakland, CaliforniaKaiser Permanente Northern California (entire region)
Sep 1, 2023
Influenza, Human Trial in Brisbane (ARCT-2138, Licensed Quadrivalent Vaccine for younger adults, Licensed Quadrivalent Vaccine
Not yet recruiting
- Influenza, Human
- ARCT-2138
- +2 more
-
Brisbane, Queensland, AustraliaNucleus Network Brisbane Clinic
Nov 8, 2023
Influenza Trial in Santiago de Compostela (Influenza vaccine)
Recruiting
- Influenza
- Influenza vaccine
-
Santiago de Compostela, A Coruña, SpainGeneral Public Health Directorate of Galician Health Service
Nov 15, 2023
Seasonal Influenza Trial in China (Quadrivalent influenza vaccine(0.25ml), Quadrivalent influenza vaccine(0.5ml), Trivalent
Not yet recruiting
- Seasonal Influenza
- Quadrivalent influenza vaccine(0.25ml)
- +3 more
-
Lu'an, Anhui, China
- +4 more
Sep 15, 2023
VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During
Not yet recruiting
- Influenza Immunization (Healthy Volunteers)
- Quadrivalent Influenza Vaccine
- High-Dose Quadrivalent Influenza Vaccine
- (no location specified)
Sep 22, 2023
Vaccination; Infection Trial (Vaccine injection)
Not yet recruiting
- Vaccination; Infection
- Vaccine injection
- (no location specified)
Oct 12, 2023
Influenza, Human Trial (Quadrivalent Influenza Vaccine (split virion, inactivated), Trivalent Influenza Vaccine (split virion,
Not yet recruiting
- Influenza, Human
- Quadrivalent Influenza Vaccine (split virion, inactivated)
- +2 more
- (no location specified)
Mar 9, 2023
Quadrivalent Influenza Vaccine Immunization Schedule for
Completed
- GCP
- Influenza Vaccine (Split Virion), Inactivated, Quadrivalent
-
Jinan, Shandong, ChinaKou Zengqiang
Oct 17, 2023
Influenza, Human Trial (sa-mRNA vaccine Dose 1, sa-mRNA vaccine Dose 2, sa-mRNA vaccine Dose 3)
Not yet recruiting
- Influenza, Human
- sa-mRNA vaccine Dose 1
- +4 more
- (no location specified)
Sep 7, 2023
Immunization; Infection, Transplantation Infection, Influenza Trial in Nashville (Standard Dose Quadrivalent Inactivated
Not yet recruiting
- Immunization; Infection
- +2 more
- Standard Dose Quadrivalent Inactivated Influenza Vaccine
- High Dose Quadrivalent Inactivated Influenza Vaccine
-
Nashville, TennesseeVanderbilt University Medical Center
Jul 11, 2023
Influenza, Influenza, Human, Influenza Viral Infections Trial in Russian Federation (Influenza vaccine [inactivated])
Completed
- Influenza
- +4 more
- Influenza vaccine [inactivated]
-
Kol'tsovo, Novosibirsk Region, Russian Federation
- +4 more
May 11, 2023
Influenza Trial in Bangkok (TetraFluvac TF vaccine, Seasonal quadrivalent vaccine-split subunit vaccine with the strains 2023)
Not yet recruiting
- Influenza
- TetraFluvac TF vaccine
- Seasonal quadrivalent vaccine-split subunit vaccine with the strains 2023
-
Bangkok, ThailandVaccine Trial Centre, Faculty of Tropical Medicine, Mahidol Univ
May 30, 2023
Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention Trial in Mechelen (ExPEC9V, Placebo, HD
Recruiting
- Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention
- ExPEC9V
- +2 more
-
Mechelen, BelgiumAz Sint-Maarten
Nov 13, 2023
Influenza, Influenza, Human, Influenza Viral Infections Trial in Russian Federation (Influenza vaccine [inactivated])
Recruiting
- Influenza
- +3 more
- Influenza vaccine [inactivated]
-
Ekaterinburg, Russian Federation
- +6 more
Feb 13, 2023
Influenza, COVID-19, Influenza Immunogencity Trial in United States (Simultaneous Vaccination (Influenza Vaccine and mRNA COVID
Not yet recruiting
- Influenza
- +3 more
- Simultaneous Vaccination (Influenza Vaccine and mRNA COVID booster)
- +2 more
-
Phoenix, Arizona
- +7 more
Aug 30, 2023
Influenza Trial in China (Quadrivalent Influenza Vaccine, Trivalent Influenza Vaccine 1 SP Shz TIV1, Trivalent Influenza Vaccine
Completed
- Influenza
- Quadrivalent Influenza Vaccine
- +2 more
-
Kunming, China
- +6 more
Nov 4, 2022
Influenza Trial in Brookvale (OVX836 480µg, Quadrivalent Inactivated Influenza Vaccine (Fluarix® Tetra), Placebo)
Completed
- Influenza
- OVX836 480µg
- +2 more
-
Brookvale, New South Wales, AustraliaNorthern Beaches Clinical Research
Dec 15, 2022
Influenza Immunization Trial (Recombinant influenza vaccine (RIV4) season/2022-2023/NH, Quadrivalent influenza vaccine (IIV4)
Not yet recruiting
- Influenza Immunization
- Recombinant influenza vaccine (RIV4) season/2022-2023/NH
- Quadrivalent influenza vaccine (IIV4) season/2022-2023/NH
- (no location specified)
Aug 23, 2022
Influenza, Behavior and Behavior Mechanisms Trial in Hellerup (Behavioral Economic Principles)
Recruiting
- Influenza
- Behavior and Behavior Mechanisms
- Behavioral Economic Principles
-
Hellerup, Hovedstaden, DenmarkCenter for Translational Cardiology and Pragmatic Randomized Tri
Sep 8, 2023
Uptake of Childhood Live Attenuated Influenza Vaccine and
Completed
- Influenza
-
London, United KingdomCPRD
Oct 4, 2023
Influenza A, Pandemic Influenza Trial in Oslo (H7HLAII)
Recruiting
- Influenza A
- Pandemic Influenza
- H7HLAII
-
Oslo, NorwayOslo University Hospital
Sep 20, 2023
Influenza Trial in Lima (FLUAD Quadrivalent, FluQuadri)
Active, not recruiting
- Influenza
- FLUAD Quadrivalent
- FluQuadri
-
Lima, Peru
- +1 more
Sep 19, 2023
Immune Response Trial in Maastricht (Influenza vaccine, Agaricus bisporus capsules, Control capsules)
Not yet recruiting
- Immune Response
- Influenza vaccine
- +2 more
-
Maastricht, Limburg, NetherlandsMaastricht University Medical Center
Sep 11, 2023
Influenza Trial in Raymond Terrace (OVX836 480µg, Quadrivalent Inactivated Influenza Vaccine (Brand 1), Quadrivalent Inactivated
Not yet recruiting
- Influenza
- OVX836 480µg
- +3 more
-
Raymond Terrace, Brisbane, AustraliaMater Misericordiae University Hospital
Feb 9, 2023
Patients Given Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine
Recruiting
- Influenza, Human
- COVID-19
- Comirnaty
- Quadrivalent Influenza Vaccine
-
New York, New YorkPfizer
May 11, 2023